02427 GUANZE MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 5.61X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.2% | Net Margin | N/A |
| Total Debt/Equity | 5.8% | Return on Equity | N/A |
| Price/Book | 12.80X | Return on Assets | N/A |
| (HKD 3.470) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -33.08 | 18.30 | 30.38 | 20.12 | 28.05 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -280.8 | -39.8 | +51.0 | -28.3 | -18.6 |
| Earnings Per Share (HKD) | -0.035 | 0.02 | 0.032 | 0.026 | 0.037 |
| Earnings Per Share Growth (%) | -281.0 | -39.1 | +21.7 | -28.9 | +100.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | 0.021 | 0.021 | No dividend |
| P/E* (X) | N/A | 177.95 | 108.44 | 131.94 | 93.78 |
| Yield (%) | N/A | N/A | 0.61 | 0.61 | N/A |
| Dividend Share (%) | N/A | N/A | 65.63 | 79.85 | N/A |
| Book NAV (HKD) | 0.271 | 0.290 | 0.313 | 0.307 | N/A |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 88.447 | 155.74 | -43.2 | 156.072 |
| Operating Result | -31.378 | 26.309 | -219.3 | 38.65 |
| Profit Before Taxation | -31.378 | 26.309 | -219.3 | 38.65 |
| Taxation | -1.417 | 8.859 | -116.0 | 10.728 |
| Profit /( Loss) After Taxation | -29.961 | 17.45 | -271.7 | 27.922 |
| Minority Interests | -0.245 | 0.246 | -199.6 | 0.355 |
| Net Profit | -29.716 | 17.204 | -272.7 | 27.567 |
| Earnings Per Share () | -0.0353 | 0.0195 | -281.0 | 0.0320 |
| Dividend Per Share () | 0.0000 | 0.0000 | N/A | 0.0210 |
| Announcement Date | 2026-03-31 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
